SCHEMBL18434655

SCHEMBL18434655

COCCNc1ccc2c(c1)-c1cc(Cl)c3cccnc3c1NS2

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC40A1 Q9NP59 14/20 0.66
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ CDC7 O00311 1/20 0.40
▸ ROCK2 O75116 1/20 0.40
▸ PIM1 P11309 1/20 0.40
▸ PRKACA P17612 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ CDK7 P50613 1/20 0.40
▸ CDK9 P50750 1/20 0.40
▸ HIPK2 Q9H2X6 1/20 0.40
▸ IRAK4 Q9NWZ3 1/20 0.40
▸ GRM4 Q14833 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ CCR1 P32246 1/20 0.35
▸ CCR8 P51685 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18434466 0.83 SLC40A1 (0.69) SLC40A1SMN1; SMN2KDM4E
SCHEMBL18434703 0.80 SLC40A1 (0.69) SLC40A1SMN1; SMN2KDM4EALDH1A1HTT
SCHEMBL11973821 0.79 SLC40A1 (1.00) SLC40A1
SCHEMBL18434826 0.79 SLC40A1 (0.63) SLC40A1SMN1; SMN2KDM4EALDH1A1CDC7
SCHEMBL18434667 0.78 SLC40A1 (0.65) SLC40A1SMN1; SMN2KDM4EALDH1A1HTT
SCHEMBL18434683 0.78 SLC40A1 (0.62) SLC40A1SMN1; SMN2KDM4EALDH1A1HTT
SCHEMBL18434845 0.76 SLC40A1 (0.58) SLC40A1SMN1; SMN2KDM4EALDH1A1HTT
SCHEMBL18434673 0.75 SLC40A1 (0.44) SLC40A1SMN1; SMN2KDM4EALDH1A1HTT
SCHEMBL18434496 0.75 SLC40A1 (0.61) SLC40A1SMN1; SMN2KDM4EALDH1A1HTT
SCHEMBL18434412 0.75 SLC40A1 (0.55) SLC40A1SMN1; SMN2KDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2675526-B1 NOVEL SULFONAMINOQUINOLINE HEPCIDIN ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2017-02-01 — — EP disclosed
Send feedback